Glowing dye to help surgeons remove more brain tumor tissue
Part of Cancer clinical trials.
This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Have a newly diagnosed, single brain tumor that appears aggressive (high-grade) on MRI and is planned for removal with a goal of taking out at least 98% of the enhancing part.
- Have not had any prior treatment for this tumor (like surgery, radiation, or chemotherapy).
- Be generally able to care for yourself (Karnofsky performance score of 70 or higher).
- Be willing to use effective birth control (if applicable) during the trial and for 30 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of three treatments for newly diagnosed high-grade glioma: a drug called ADI-PEG 20, chemotherapy (temozolomide), and radiation therapy. The goal is to see if this combination is safe and effective for children and young adults with this type of brain or spinal cord tumor.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.
Hear when a new High-Grade Glioma (WHO III-IV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.